Search Results - "International journal of oncology"

Refine Results
  1. 1

    From chemotherapy to biological therapy: A review of novel concepts to reduce the side effects of systemic cancer treatment (Review) by Schirrmacher, Volker

    Published in International journal of oncology (01-02-2019)
    “…The side effects of systemic chemotherapy used to treat cancer are often severe. For decades, oncologists have focused on treating the tumor, which may result…”
    Get full text
    Journal Article
  2. 2

    Triple‑negative breast cancer therapy: Current and future perspectives (Review) by Won, Kwang-Ai, Spruck, Charles

    Published in International journal of oncology (01-12-2020)
    “…Triple-negative breast cancer (TNBC) accounts for 10-15% of all breast cancer cases. TNBCs lack estrogen and progesterone receptors and express low levels of…”
    Get full text
    Journal Article
  3. 3

    Anticancer peptide: Physicochemical property, functional aspect and trend in clinical application (Review) by Chiangjong, Wararat, Chutipongtanate, Somchai, Hongeng, Suradej

    Published in International journal of oncology (01-09-2020)
    “…Cancer is currently ineffectively treated using therapeutic drugs, and is also able to resist drug action, resulting in increased side effects following drug…”
    Get full text
    Journal Article
  4. 4

    Mechanisms and management of 3rd‑generation EGFR‑TKI resistance in advanced non‑small cell lung cancer (Review) by He, Jingyi, Huang, Zhengrong, Han, Linzhi, Gong, Yan, Xie, Conghua

    Published in International journal of oncology (01-11-2021)
    “…Targeted therapy with epidermal growth factor receptor (EGFR)‑tyrosine kinase inhibitors (TKIs) is a standard modality of the 1st‑line treatments for patients…”
    Get full text
    Journal Article
  5. 5

    The Akt pathway in oncology therapy and beyond (Review) by Nitulescu, George Mihai, Van De Venter, Maryna, Nitulescu, Georgiana, Ungurianu, Anca, Juzenas, Petras, Peng, Qian, Olaru, Octavian Tudorel, Grădinaru, Daniela, Tsatsakis, Aristides, Tsoukalas, Dimitris, Spandidos, Demetrios A, Margina, Denisa

    Published in International journal of oncology (01-12-2018)
    “…Protein kinase B (Akt), similar to many other protein kinases, is at the crossroads of cell death and survival, playing a pivotal role in multiple…”
    Get full text
    Journal Article
  6. 6

    The epitranscriptome m6A writer METTL3 promotes chemo- and radioresistance in pancreatic cancer cells by Taketo, Kosuke, Konno, Masamitsu, Asai, Ayumu, Koseki, Jun, Toratani, Masayasu, Satoh, Taroh, Doki, Yuichiro, Mori, Masaki, Ishii, Hideshi, Ogawa, Kazuhiko

    Published in International journal of oncology (01-02-2018)
    “…N6-methyladenosine (m6A) is the most abundant epitranscriptome modification in mammalian mRNA. Recent years have seen substantial progress in m6A…”
    Get full text
    Journal Article
  7. 7

    Canonical and non-canonical WNT signaling in cancer stem cells and their niches: Cellular heterogeneity, omics reprogramming, targeted therapy and tumor plasticity (Review) by Katoh, Masaru

    Published in International journal of oncology (01-11-2017)
    “…Cancer stem cells (CSCs), which have the potential for self-renewal, differentiation and de-differentiation, undergo epigenetic, epithelial-mesenchymal,…”
    Get full text
    Journal Article
  8. 8

    The post-translational modification, SUMOylation, and cancer (Review) by Han, Zhi-Jian, Feng, Yan-Hu, Gu, Bao-Hong, Li, Yu-Min, Chen, Hao

    Published in International journal of oncology (01-04-2018)
    “…SUMOylation is a reversible post-translational modification which has emerged as a crucial molecular regulatory mechanism, involved in the regulation of DNA…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Piperlongumine rapidly induces the death of human pancreatic cancer cells mainly through the induction of ferroptosis by Yamaguchi, Yuki, Kasukabe, Takashi, Kumakura, Shunichi

    Published in International journal of oncology (01-03-2018)
    “…Pancreatic cancer is one of the most lethal types of cancer with a mortality rate of almost 95%. Treatment with current chemotherapeutic drugs has limited…”
    Get full text
    Journal Article
  11. 11

    Exosome-mediated transfer of lncRNA‑SNHG14 promotes trastuzumab chemoresistance in breast cancer by Dong, Huaying, Wang, Wei, Chen, Ru, Zhang, Yu, Zou, Kejian, Ye, Mulin, He, Xionghui, Zhang, Fan, Han, Jing

    Published in International journal of oncology (01-09-2018)
    “…Currently, resistance to trastuzumab, a human epidermal growth factor receptor 2 (HER2) inhibitor, has become an important obstacle to improving the clinical…”
    Get full text
    Journal Article
  12. 12

    Akt inhibitors in cancer treatment: The long journey from drug discovery to clinical use (Review) by NITULESCU, GEORGE MIHAI, MARGINA, DENISA, JUZENAS, PETRAS, PENG, QIAN, OLARU, OCTAVIAN TUDOREL, SALOUSTROS, EMMANOUIL, FENGA, CONCETTINA, SPANDIDOS, DEMETRIOS A, LIBRA, MASSIMO, TSATSAKIS, ARISTIDIS M

    Published in International journal of oncology (01-03-2016)
    “…Targeted cancer therapies are used to inhibit the growth, progression, and metastasis of the tumor by interfering with specific molecular targets and are…”
    Get full text
    Journal Article
  13. 13

    The EGFR pathway is involved in the regulation of PD-L1 expression via the IL-6/JAK/STAT3 signaling pathway in EGFR-mutated non-small cell lung cancer by Zhang, Nan, Zeng, Yuanyuan, Du, Wenwen, Zhu, Jianjie, Shen, Dan, Liu, Zeyi, Huang, Jian-an

    Published in International journal of oncology (01-10-2016)
    “…Negative regulation of the signal mediated by the programmed cell death protein 1 (PD-1)/programmed death-ligand 1 (PD-L1) pathway can effectively inhibit the…”
    Get full text
    Journal Article
  14. 14

    Cancer‑associated fibroblast‑induced M2‑polarized macrophages promote hepatocellular carcinoma progression via the plasminogen activator inhibitor‑1 pathway by Chen, Shuhai, Morine, Yuji, Tokuda, Kazunori, Yamada, Shinichiro, Saito, Yu, Nishi, Masaaki, Ikemoto, Tetsuya, Shimada, Mitsuo

    Published in International journal of oncology (01-08-2021)
    “…Targeting the tumor stroma is an important strategy in cancer treatment. Cancer-associated fibroblasts (CAFs) and tumor-associated macrophages (TAMs) are two…”
    Get full text
    Journal Article
  15. 15

    Influence of doxorubicin on apoptosis and oxidative stress in breast cancer cell lines by Pilco-Ferreto, Nesstor, Calaf, Gloria M

    Published in International journal of oncology (01-08-2016)
    “…Breast cancer is one of the leading causes of mortality among women worldwide due to aggressive behavior, early metastasis, resistance to existing…”
    Get full text
    Journal Article
  16. 16

    Oncological role of HMGA2 (Review) by Zhang, Shizhen, Mo, Qiuping, Wang, Xiaochen

    Published in International journal of oncology (01-10-2019)
    “…The high mobility group A2 (HMGA2) protein is a non‑histone architectural transcription factor that modulates the transcription of several genes by binding to…”
    Get full text
    Journal Article
  17. 17

    Serine, glycine and one‑carbon metabolism in cancer (Review) by Pan, Sijing, Fan, Ming, Liu, Zhangnan, Li, Xia, Wang, Huijuan

    Published in International journal of oncology (01-02-2021)
    “…Serine/glycine biosynthesis and one‑carbon metabolism are crucial in sustaining cancer cell survival and rapid proliferation, and of high clinical relevance…”
    Get full text
    Journal Article
  18. 18

    GSTP1 and cancer: Expression, methylation, polymorphisms and signaling (Review) by Cui, Jian, Li, Guoqing, Yin, Jie, Li, Linwei, Tan, Yue, Wei, Haoran, Liu, Bang, Deng, Lihong, Tang, Jialu, Chen, Yonglin, Yi, Lan

    Published in International journal of oncology (01-04-2020)
    “…Glutathione S‑transferase Pi (GSTP1) is an isozyme encoded by the GST pi gene that plays an important regulatory role in detoxification, anti‑oxidative damage,…”
    Get full text
    Journal Article
  19. 19

    Circulating tumor cell clusters: What we know and what we expect (Review) by Hong, Yupeng, Fang, Francia, Zhang, Qi

    Published in International journal of oncology (01-12-2016)
    “…The major cause of cancer-associated mortality is tumor metastasis, a disease that is far from understood. Many studies have observed circulating tumor cells…”
    Get full text
    Journal Article
  20. 20

    Proteomics profiling of plasma exosomes in epithelial ovarian cancer: A potential role in the coagulation cascade, diagnosis and prognosis by Zhang, Wei, Ou, Xiaoxuan, Wu, Xiaohua

    Published in International journal of oncology (01-05-2019)
    “…Ovarian cancer remains the most lethal type of cancer among all gynecological malignancies. The majority of patients are diagnosed with ovarian cancer at the…”
    Get full text
    Journal Article